5-(chloromethyl)-1-(3-ethoxypropyl)-2-methanesulfonyl-1H-imidazole, 95.0%, 2g

[1-(2-methoxyethyl)-1H-imidazol-2-yl]methanamine hydrochloride, 1g

1-(Pyridin-4-yl)butan-1-one, 95.0%, 250mg

3-methyl-1-(2-methylpiperazin-1-yl)butan-1-one, 95.0%, 2g

TERT-BUTYL-3-(1-HYDROXYETHYL)PYRROLIDINE-1-CARBOXYLATE, 95.0%, 1g

(2E)-1-(4-bromophenyl)-3-(3-fluorophenyl)prop-2-en-1-one, 95.0%, 10g

2-Aminobenzhydrol, 95.0%, 1g

3-Bromophenylboronic acid, 98.0%, 5g

1-Bromo-3-fluoro-2-isopropoxy-4-methylbenzene, 98%, 1g

(S)-4-(tert-Butoxycarbonyl)-3-methylmorpholine-3-carboxylic acid, 97%, 100mg

3-(2,5-Difluorobenzoyl)-4-methylpyridine, 97.0%, 1g

Furo[3,4-b]furo[3',4':5,6]pyrazino[2,3-f]furo[3',4':5,6]pyrazino[2,3-h]quinoxaline-1,3,6,8,11,13-hexaone, 95%, 100mg

Formic acid D2 95% solution in D2O, 98 at%D, 5 ml, glass packaging